Production (Stage)
MIRA Pharmaceuticals, Inc.
MIRA
$1.40
$0.032.19%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/28/2025
-
GuruFocus
5/28/2025
-
GuruFocus
5/28/2025
-
GuruFocus
5/28/2025
-
The Fly
5/28/2025
-
Accesswire
5/11/2025
-
Market Exclusive
5/8/2025
-
GuruFocus
5/8/2025
-
GuruFocus
5/8/2025
-
SeekingAlpha.com: All News
5/8/2025
-
Seeking Alpha - Healthcare
5/8/2025
-
The Fly
5/8/2025
-
GuruFocus
5/8/2025
-
TipRanks Financial Blog
5/8/2025
-
Accesswire
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
The Fly
5/6/2025
-
Accesswire
EXCLUSIVE: MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study
5/6/2025
-
Benzinga
4/27/2025
-
Market Exclusive
4/23/2025
-
GuruFocus
4/23/2025
-
Seeking Alpha - Healthcare
4/23/2025
-
GuruFocus
4/23/2025
-
TipRanks Financial Blog
4/23/2025
-
The Fly
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 14, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
786-432-9792
Address
1200 Brickell Avenue
Miami, FL 32183
Miami, FL 32183
Country
Year Founded
Business Description
Sector
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The...
more